Genetic mutations in many forms of ALS lead to early problems with the transport and function of mitochondria, a study found.

The ALS Network is supporting research using electronic health records to identify existing drugs for repurposing to slow ALS ...

ATH-1105, an experimental oral therapy for ALS, was found to be safe and well tolerated in healthy adult volunteers in a ...

Patients with less neuronal damage, determined by low spinal fluid pNFH, had a 48% reduction in the risk of death by adding ...

What does coping mean in life? Columnist Kristin Neva mulls it over after she and her husband with ALS take a mental health survey.

The FDA has cleared Brainstorm to initiate a Phase 3b clinical trial testing NurOwn (debamestrocel) in people with moderate ALS.